Trauma & Fusion

Forging effective new treatments in trauma and fusion

It’s estimated that around one-and-a-half million instrumented spinal procedures will be performed in the United States in 2023-2024¹; while trauma injuries account for three million non-fatal injuries per year². Continued innovation clearly holds the key to improving the efficiency and accuracy of treatments; and this is why our biomaterials experts are working closer than ever with our partners to increase the strength, ease-of-use and wear resistance of bone graft substitutes used in orthopedic implants.

^{1. iData Research, 2023, 2. The American Association for the Surgery of Trauma}

We work with partners worldwide across the continuum of healthcare to co-create unique trauma and fusion solutions that support patient healing – and bring progress to life

30+ Years

Of experience in developing orthopedic solutions.

1 Second

Every second a patient receives a medical device containing a dsm-firmenich Biomedical solution.

25 Master Files

25 FDA Material Master Files available to support regulatory submissions.

healthy lifestyle young fitness sports woman running on seaside boardwalk

Challenges in trauma and fusion

We see a market that recognizes the potential for new materials to help solve some of its greatest challenges. For example, preventing the need for implant removals in trauma applications has huge possibilities for both patients and medical providers. However, achieving this requires biocompatible materials that are proven to perform safely - and can reliably degrade slowly over time as the patient heals.

Another key trend is the demand from surgeons for improved handling abilities of bone grafts, which can best be achieved through new materials that give them increased versatility in the OR – as well as the osteoconductive properties needed to ensure predictable fusions. Today, our experts are working to address all of these challenges (and more).

Discover our integrated biomaterial portfolio for trauma & fusion

Spine and Chondromyxoid fibroma

Our experts draw on a broad biomaterial portfolio to support the body’s natural healing response and potentially improve patient outcomes in spinal, trauma and chondromyxoid fibroma applications. These biocompatible materials can be fine-tuned and customized based on your unique application needs.

Bone graft substitutes

Our bioinductive and trimmable bone graft substitutes support bone regeneration in your orthopedic devices – while minimizing the risk of donor-site morbidity and infections for patients. For example, our injectable, biomimetic ceramic putties deliver bone graft material precisely to promote fusion and stimulate osteogenesis.

We also offer arthroscopically injectable bone void fillers; as well as highly durable spacers and load-bearing materials in the form of our biocompatible medical polyurethanes. They help support joints and the spine while reducing adverse reactions in patients during surgery.

Subchondral cysts & bone defects

Here, our drillable bone void fillers enable accurate and tailored bone healing during orthopedic surgery.

Trauma

For trauma procedures – including cerclage applications – our Ultra High Molecular Weight Polyethylene fiber delivers excellent tensile strength and reliable, secure fixation.